Pulse Biosciences, Inc. ( PLSE) - Key Metrics
PLSE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0 | -$0.26 | -$0.22 | -$0.22 |
| 2025Q3 | $0 | -$0.29 | -$0.19 | -$0.19 |
| 2025Q2 | ? | -$0.28 | -$0.19 | -$0.19 |
| 2025Q1 | ? | -$0.25 | -$0.20 | -$0.20 |
PLSE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -13.27 |
| 2025Q3 | ? | -15.38 |
| 2025Q2 | ? | -13.24 |
| 2025Q1 | ? | -16.08 |
PLSE Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | -1.61% | ? |
| 2025Q3 | -1.10% | ? |
| 2025Q2 | -1.27% | ? |
| 2025Q1 | -1.26% | ? |
PLSE
Price: $26.94
52 week price:
Earnings Per Share: -1.10 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 25600
Ebitda: -14.3 millionMarket Capitalization: 1.3 billion